Colorectal Cancer

People with MS had an increased risk for bladder, brain and cervical cancers compared with people without MS, according to a new study in Neurology, the medical journal of the American Academy of Neurology.

In a video exclusive, Craig Munroe, MD, discusses how recent revisions to quality indicators for colonoscopy from ACG and ASGE may improve patient outcomes by raising the standards of the procedure.

The FDA approved Exact Sciences’ Cologuard Plus multitarget stool DNA test to screen adults aged 45 years or older at average risk for colorectal cancer, according to a company press release.

Despite a twofold increase in colorectal cancer screening among average-risk individuals aged 45 to 49 years after the 2021 recommendation, disparities in socioeconomic status and locality underscore the need for targeted interventions.

Delays in cancer registration may have underestimated 10-year colorectal cancer risk reductions by up to 75% in the NordICC trial, with researchers warning that study estimates on screening colonoscopy should be “interpreted with caution.”

A randomized phase 3 trial designed to compare an investigational combination with standard care for certain patients with advanced colorectal cancer failed to meet its primary endpoint of OS.

Following a July boom in game-changing FDA approvals for gastroenterology, including the first blood test for colorectal cancer, the agency has succumbed to the summer lull with only three approvals for GI to close out the season.

The development of more effective treatments — including personalized therapies — have dramatically improved outcomes for children and adolescents with cancer, according to American Association for Cancer Research’s Cancer Progress Report.

The American Society of Transplantation has asked CMS to delay up to a year the launch of a 6-year demonstration aimed at increasing kidney transplants and improvements in graft survival. 

Although training primary care providers in shared decision-making did not significantly improve colorectal cancer concordance or screening rates in older adults, at least 5 minutes of discussion with a PCP may benefit some, data showed.